GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Motus GI Holdings Inc (OTCPK:MOTS) » Definitions » 10-Year RORE %

Motus GI Holdings (Motus GI Holdings) 10-Year RORE % : 0.00% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Motus GI Holdings 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Motus GI Holdings does not have enough data to calculate 10-Year RORE %.


Motus GI Holdings 10-Year RORE % Historical Data

The historical data trend for Motus GI Holdings's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Motus GI Holdings 10-Year RORE % Chart

Motus GI Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only - - - - -

Motus GI Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Motus GI Holdings's 10-Year RORE %

For the Medical Devices subindustry, Motus GI Holdings's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Motus GI Holdings's 10-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's 10-Year RORE % falls into.



Motus GI Holdings 10-Year RORE % Calculation

Motus GI Holdings's 10-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 10-year before.


Motus GI Holdings  (OTCPK:MOTS) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Motus GI Holdings 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Motus GI Holdings's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Motus GI Holdings (Motus GI Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
Executives
Orchestra Biomed Holdings, Inc. 10 percent owner 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Scott Durbin director PO BOX 376, ANN ARBOR MI 48106
Elad Amor officer: Chief Accounting Officer MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Ravit Ram officer: Chief Financial Officer MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Timothy P. Moran director, officer: Chief Executive Officer C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Andrew Lawrence Taylor officer: Chief Financial Officer C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Mark Pomeranz director, officer: President and COO C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Sonja Nelson director C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BOULEVARD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Oracle Partners Lp other: * See Remarks 200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg other: * See Remarks C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Darren Sherman director C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
David P Hochman director, other: Chairman of the Board 15 WESTON HILL RD., RIVERSIDE CT 06878
Nussbaum Samuel R Md director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Shervin J Korangy director 850 PARK AVENUE, APT. 12B, NEW YORK NY 10075